Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Ip JC, Pang TC, Glover AR, Soon P, Zhao JT, Clarke S, Robinson BG, Gill AJ, Sidhu SB.

Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.

PMID:
25657202
2.

Bilateral recurrent laryngeal nerve injury in a specialized thyroid surgery unit: would routine intraoperative neuromonitoring alter outcomes?

Sarkis LM, Zaidi N, Norlén O, Delbridge LW, Sywak MS, Sidhu SB.

ANZ J Surg. 2015 Feb 3. doi: 10.1111/ans.12980. [Epub ahead of print]

PMID:
25648744
3.

Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence.

Glover AR, Zhao JT, Ip JC, Lee JC, Robinson BG, Gill AJ, Soon PS, Sidhu SB.

Endocr Relat Cancer. 2015 Feb;22(1):99-109. doi: 10.1530/ERC-14-0457.

PMID:
25595289
4.

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma.

Chou A, Fraser S, Toon CW, Clarkson A, Sioson L, Farzin M, Cussigh C, Aniss A, O'Neill C, Watson N, Clifton-Bligh RJ, Learoyd DL, Robinson BG, Selinger CI, Delbridge LW, Sidhu SB, O'Toole SA, Sywak M, Gill AJ.

Am J Surg Pathol. 2015 May;39(5):652-9. doi: 10.1097/PAS.0000000000000368.

PMID:
25501013
5.

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer.

Gundara JS, Zhao J, Gill AJ, Lee JC, Delbridge L, Robinson BG, McLean C, Serpell J, Sidhu SB.

Cancer Med. 2015 Feb;4(2):174-82. doi: 10.1002/cam4.355. Epub 2014 Dec 8.

6.

The Covidien LigaSure Maryland Jaw Device.

Zaidi N, Glover AR, Sidhu SB.

Expert Rev Med Devices. 2015 Mar;12(2):151-5. doi: 10.1586/17434440.2015.985650. Epub 2014 Nov 28.

PMID:
25431842
7.

The Australian experience with the Bethesda classification system for thyroid fine needle aspiration biopsies.

Sarkis LM, Norlen O, Aniss A, Watson N, Delbridge LW, Sidhu SB, Sywak MS, Gill AJ.

Pathology. 2014 Dec;46(7):592-5. doi: 10.1097/PAT.0000000000000168.

PMID:
25393248
8.

Re: Avoiding recurrent laryngeal nerve injury in thyroid surgery.

Serpell JW, Sidhu SB.

ANZ J Surg. 2014 Nov;84(11):895-6. doi: 10.1111/ans.12901. No abstract available.

PMID:
25348920
9.

MicroRNA expression profiles in the management of papillary thyroid cancer.

Lee JC, Gundara JS, Glover A, Serpell J, Sidhu SB.

Oncologist. 2014 Nov;19(11):1141-7. doi: 10.1634/theoncologist.2014-0135. Epub 2014 Oct 16.

PMID:
25323484
10.

Use of the Nerve Integrity Monitor during Thyroid Surgery Aids Identification of the External Branch of the Superior Laryngeal Nerve.

Glover AR, Norlén O, Gundara JS, Morris M, Sidhu SB.

Ann Surg Oncol. 2014 Oct 16. [Epub ahead of print]

PMID:
25319580
11.

Improving Outcomes in Adrenocortical Cancer: An Australian Perspective.

Ip JC, Pang TC, Glover AR, Soon P, Clarke S, Richardson A, Campbell P, Robinson BG, Sidhu SB.

Ann Surg Oncol. 2014 Oct 16. [Epub ahead of print]

PMID:
25319576
12.

The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.

Glover AR, Gundara JS, Norlén O, Lee JC, Sidhu SB.

Gland Surg. 2013 Nov;2(4):196-205. doi: 10.3978/j.issn.2227-684X.2013.10.05. Review.

13.

Noncoding RNAs in endocrine malignancy.

Kentwell J, Gundara JS, Sidhu SB.

Oncologist. 2014 May;19(5):483-91. doi: 10.1634/theoncologist.2013-0458. Epub 2014 Apr 9. Review.

PMID:
24718512
14.

Thyroidal abscesses in third and fourth branchial anomalies: not only a paediatric diagnosis.

Kruijff S, Sywak MS, Sidhu SB, Shun A, Novakovic D, Lee JC, Delbridge LW.

ANZ J Surg. 2014 Mar 27. doi: 10.1111/ans.12576. [Epub ahead of print]

PMID:
24674380
15.

Four-dimensional computed tomography for parathyroid localization: a new imaging modality.

Brown SJ, Lee JC, Christie J, Maher R, Sidhu SB, Sywak MS, Delbridge LW.

ANZ J Surg. 2014 Mar 27. doi: 10.1111/ans.12571. [Epub ahead of print]

PMID:
24674300
16.

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.

Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PSh.

BMC Cancer. 2014 Mar 18;14:200. doi: 10.1186/1471-2407-14-200.

17.

Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma.

Kruijff S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, Clifton-Bligh RJ, Roach P, Gill AJ, Learoyd D, Sywak MS.

Surgery. 2013 Dec;154(6):1337-44; discussion 1344-5.

PMID:
24383104
18.

MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB.

Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.

19.

Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.

Ip JC, Pang TC, Pon CK, Zhao JT, Sywak MS, Gill AJ, Soon PS, Sidhu SB.

ANZ J Surg. 2015 Apr;85(4):279-83. doi: 10.1111/ans.12470. Epub 2013 Nov 26.

PMID:
24274318
20.

Patterns of structural recurrence in papillary thyroid cancer.

Kruijff S, Petersen JF, Chen P, Aniss AM, Clifton-Bligh RJ, Sidhu SB, Delbridge LW, Gill AJ, Learoyd D, Sywak MS.

World J Surg. 2014 Mar;38(3):653-9. doi: 10.1007/s00268-013-2286-0.

PMID:
24149717
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk